|
76
|
|
18
|
+9
|
+100%
|
US$ 1 mi
|
|
|
77
|
|
17
|
-1
|
-6%
|
US$ 270 mil
|
|
|
78
|
|
17
|
+2
|
+13%
|
US$ 155 mil
|
|
|
79
|
Deslistada
Lunai Bioworks
|
16
|
-11
|
-41%
|
US$ 641 mil
|
|
|
80
|
|
16
|
+2
|
+14%
|
US$ 55,3 mil
|
|
|
81
|
Creative Medical Technology
|
15
|
+4
|
+36%
|
US$ 541 mil
|
|
|
82
|
|
15
|
-1
|
-6%
|
US$ 4,99 mi
|
|
|
83
|
|
9
|
-6
|
-40%
|
US$ 236 mil
|
|
|
84
|
|
9
|
-2
|
-18%
|
US$ 1,33 mi
|
|
|
85
|
|
9
|
+9
|
–
|
US$ 2,78 mi
|
|
|
86
|
Deslistada
SANGAMO THERAPEUTICS INC
|
6
|
-107
|
-95%
|
US$ 29 mil
|
|
|
87
|
|
4
|
0
|
0%
|
US$ 42,6 mil
|
|
|
88
|
Deslistada
Achilles Therapeutics
|
3
|
0
|
0%
|
US$ 98,9 mil
|
|
|
89
|
|
3
|
0
|
0%
|
US$ 12,2 mil
|
|
|
90
|
|
2
|
-238
|
-99%
|
US$ 3,43 mi
|
|
|
91
|
Deslistada
Athersys, Inc. Common Stock
|
1
|
0
|
0%
|
–
|
|
|
92
|
Deslistada
Carisma Therapeutics
|
1
|
-2
|
-67%
|
US$ 4
|
|
|
93
|
Deslistada
CATALENT, INC.
|
1
|
0
|
0%
|
US$ 63
|
|
|
94
|
Deslistada
Generation Bio
|
1
|
-1
|
-50%
|
US$ 0
|
|
|
95
|
Deslistada
NKGen Biotech, Inc. Common Stock
|
1
|
0
|
0%
|
US$ 165 mil
|
|
|
96
|
Deslistada
Scorpius Holdings, Inc.
|
1
|
0
|
0%
|
US$ 1
|
|
|
97
|
Deslistada
Sio Gene Therapies Inc. Common Stock
|
1
|
+1
|
–
|
US$ 235 mil
|
|
|
98
|
Deslistada
Adaptimmune Therapeutics
|
0
|
-1
|
-100%
|
US$ 0
|
|
|
99
|
Deslistada
Adverum Biotechnologies
|
–
|
–
|
–
|
–
|
|
|
100
|
Deslistada
Applied Genetic Technologies Corporation
|
–
|
–
|
–
|
–
|
|
